About this episode

This episode discusses the latest advancements in the treatment of Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia, featuring expert insights from leading oncologists.

Featuring perspectives from Dr Farrukh T Awan, Dr Brad S Kahl, Ms Robin Klebig and Ms Mollie Moran, moderated by Dr Kahl, including the following topics: Introduction: Biology of Non-Hodgkin Lymphoma (NHL) (00:00) Current Role of CD20 x CD3 Bispecific Antibodies in NHL (4:49) Role of Polatuzumab Vedotin in Diffuse Large B-Cell Lymphoma (DLBCL) (27:48) Optimal Application of Loncastuximab Tesirine for Patients with DLBCL and Follicular Lymphoma (41:43) Role of Bruton Tyrosine Kinase (BTK) Inhibitors Alone or with Anti-CD20 Antibodies for Patients with Newly Diagnosed Chronic Lymphocytic Leukemia (CLL) (1:00:43) Combining BTK Inhibitors with Bcl-2 Inhibitors (1:31:15) Current and Future Role of Noncovalent BTK Inhibitors in CLL (1:41:30) CME information and select publications

More episodes of Research To Practice | Oncology Videos

• EGFR-Mutated Non-Small Cell Lung Cancer — Proceedings from a Session Held in Conjunction with the 2026 ASCO Annual Meeting · July 21, 2026 · 1h 58m
• Endometrial Cancer — Proceedings from a Session Held in Conjunction with the 2026 ASCO Annual Meeting · July 20, 2026 · 1h 30m
• HER2-Positive Metastatic Breast Cancer — An Interview with Prof Dr Sibylle Loibl on First-Line and Maintenance Therapy · July 18, 2026 · 46 min
• HER2-Positive Metastatic Breast Cancer — An Interview with Prof Dr Sibylle Loibl on First-Line and Maintenance Therapy (Companion Faculty Lecture) · July 17, 2026 · 30 min
• Ovarian Cancer — Proceedings from a Session Held in Conjunction with the 2026 ASCO Annual Meeting · July 15, 2026 · 2h 1m
• HER2-Altered Non-Small Cell Lung Cancer — Rapid Case Review · July 14, 2026 · 28 min

Explore listener stats, chart rankings, contacts and more on the Research To Practice | Oncology Videos podcast page.